0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dotinurad Tablets Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-19H18096
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dotinurad Tablets Market Research Report 2024
BUY CHAPTERS

Global Dotinurad Tablets Market Research Report 2026

Code: QYRE-Auto-19H18096
Report
2026-02-11
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dotinurad Tablets Market Size

The global Dotinurad Tablets market was valued at US$ 72 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 15.0% from 2026 to 2032.

Dotinurad Tablets Market

Dotinurad Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dotinurad Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dotinurad tablets belong to a class of medications known as selective uric acid reabsorption inhibitors.They are primarily prescribed for the treatment of hyperuricemia associated with gout.By blocking URAT1,Dotinurad increases the excretion of uric acid in the urine,thereby lowering blood uric acid levels and reducing the risk of urate crystal formation in joints and tissues.
Dotinurad is a first-in-class Selective Urate Reabsorption Inhibitor (SURI) that lowers serum uric acid levels by selectively inhibiting the URAT1 transporter in the renal proximal tubule, enhancing uric acid excretion. Developed by Eisai, it was first approved in Japan in 2020 and subsequently received marketing authorization in China in December 2024 under the brand name Urelice®. Compared to xanthine oxidase inhibitors like allopurinol and febuxostat, Dotinurad offers a differentiated safety and efficacy profile, particularly in patients with renal dysfunction or intolerance to XOIs. With over 10 million gout patients in China and limited treatment penetration, Dotinurad addresses a significant unmet clinical need. Its novel mechanism, favorable tolerability, and strategic positioning as the first SURI approved in China highlight its strong commercial potential and licensing value in the evolving urate-lowering therapy landscape.
This report delivers a comprehensive overview of the global Dotinurad Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dotinurad Tablets. The Dotinurad Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dotinurad Tablets market comprehensively. Regional market sizes by Type, by Application, by Technology, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dotinurad Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Dotinurad Tablets Market Report

Report Metric Details
Report Name Dotinurad Tablets Market
Accounted market size in 2025 US$ 72 in million
Forecasted market size in 2032 US$ 189 million
CAGR 15.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 0.5mg per Tablet
  • 1.0mg per Tablet
  • 2.0mg per Tablet
Segment by Technology
  • Original Drug
  • Generic Drug
by Application
  • Hyperuricaemia
  • Gout
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fuji Yakuhin, Mochida Pharmaceutical, Eisai, Ziska Pharmaceutical, General Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Dotinurad Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Dotinurad Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Dotinurad Tablets Market growing?

Ans: The Dotinurad Tablets Market witnessing a CAGR of 15.0% during the forecast period 2026-2032.

What is the Dotinurad Tablets Market size in 2032?

Ans: The Dotinurad Tablets Market size in 2032 will be US$ 189 million.

Who are the main players in the Dotinurad Tablets Market report?

Ans: The main players in the Dotinurad Tablets Market are Fuji Yakuhin, Mochida Pharmaceutical, Eisai, Ziska Pharmaceutical, General Pharmaceuticals

What are the Application segmentation covered in the Dotinurad Tablets Market report?

Ans: The Applications covered in the Dotinurad Tablets Market report are Hyperuricaemia, Gout, Other

What are the Type segmentation covered in the Dotinurad Tablets Market report?

Ans: The Types covered in the Dotinurad Tablets Market report are 0.5mg per Tablet, 1.0mg per Tablet, 2.0mg per Tablet

1 Dotinurad Tablets Market Overview
1.1 Product Definition
1.2 Dotinurad Tablets by Type
1.2.1 Global Dotinurad Tablets Market Value by Type: 2025 vs 2032
1.2.2 0.5mg per Tablet
1.2.3 1.0mg per Tablet
1.2.4 2.0mg per Tablet
1.3 Dotinurad Tablets by Technology
1.3.1 Global Dotinurad Tablets Market Value by Technology: 2025 vs 2032
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Dotinurad Tablets by Application
1.4.1 Global Dotinurad Tablets Market Value by Application: 2025 vs 2032
1.4.2 Hyperuricaemia
1.4.3 Gout
1.4.4 Other
1.5 Global Dotinurad Tablets Market Size Estimates and Forecasts
1.5.1 Global Dotinurad Tablets Revenue 2021–2032
1.5.2 Global Dotinurad Tablets Sales 2021–2032
1.5.3 Global Dotinurad Tablets Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Dotinurad Tablets Market Competition by Manufacturers
2.1 Global Dotinurad Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dotinurad Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dotinurad Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dotinurad Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dotinurad Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dotinurad Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Dotinurad Tablets, Date of Entry into the Industry
2.8 Global Dotinurad Tablets Market Competitive Situation and Trends
2.8.1 Global Dotinurad Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dotinurad Tablets Players Market Share by Revenue
2.8.3 Global Dotinurad Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dotinurad Tablets Market Scenario by Region
3.1 Global Dotinurad Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dotinurad Tablets Sales by Region: 2021–2032
3.2.1 Global Dotinurad Tablets Sales by Region: 2021–2026
3.2.2 Global Dotinurad Tablets Sales by Region: 2027–2032
3.3 Global Dotinurad Tablets Revenue by Region: 2021–2032
3.3.1 Global Dotinurad Tablets Revenue by Region: 2021–2026
3.3.2 Global Dotinurad Tablets Revenue by Region: 2027–2032
3.4 North America Dotinurad Tablets Market Facts & Figures by Country
3.4.1 North America Dotinurad Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dotinurad Tablets Sales by Country (2021–2032)
3.4.3 North America Dotinurad Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dotinurad Tablets Market Facts & Figures by Country
3.5.1 Europe Dotinurad Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dotinurad Tablets Sales by Country (2021–2032)
3.5.3 Europe Dotinurad Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dotinurad Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Dotinurad Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dotinurad Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Dotinurad Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dotinurad Tablets Market Facts & Figures by Country
3.7.1 Latin America Dotinurad Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dotinurad Tablets Sales by Country (2021–2032)
3.7.3 Latin America Dotinurad Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dotinurad Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dotinurad Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dotinurad Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dotinurad Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dotinurad Tablets Sales by Type (2021–2032)
4.1.1 Global Dotinurad Tablets Sales by Type (2021–2026)
4.1.2 Global Dotinurad Tablets Sales by Type (2027–2032)
4.1.3 Global Dotinurad Tablets Sales Market Share by Type (2021–2032)
4.2 Global Dotinurad Tablets Revenue by Type (2021–2032)
4.2.1 Global Dotinurad Tablets Revenue by Type (2021–2026)
4.2.2 Global Dotinurad Tablets Revenue by Type (2027–2032)
4.2.3 Global Dotinurad Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Dotinurad Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dotinurad Tablets Sales by Application (2021–2032)
5.1.1 Global Dotinurad Tablets Sales by Application (2021–2026)
5.1.2 Global Dotinurad Tablets Sales by Application (2027–2032)
5.1.3 Global Dotinurad Tablets Sales Market Share by Application (2021–2032)
5.2 Global Dotinurad Tablets Revenue by Application (2021–2032)
5.2.1 Global Dotinurad Tablets Revenue by Application (2021–2026)
5.2.2 Global Dotinurad Tablets Revenue by Application (2027–2032)
5.2.3 Global Dotinurad Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Dotinurad Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Fuji Yakuhin
6.1.1 Fuji Yakuhin Company Information
6.1.2 Fuji Yakuhin Description and Business Overview
6.1.3 Fuji Yakuhin Dotinurad Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Fuji Yakuhin Dotinurad Tablets Product Portfolio
6.1.5 Fuji Yakuhin Recent Developments/Updates
6.2 Mochida Pharmaceutical
6.2.1 Mochida Pharmaceutical Company Information
6.2.2 Mochida Pharmaceutical Description and Business Overview
6.2.3 Mochida Pharmaceutical Dotinurad Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mochida Pharmaceutical Dotinurad Tablets Product Portfolio
6.2.5 Mochida Pharmaceutical Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Company Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Dotinurad Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eisai Dotinurad Tablets Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Ziska Pharmaceutical
6.4.1 Ziska Pharmaceutical Company Information
6.4.2 Ziska Pharmaceutical Description and Business Overview
6.4.3 Ziska Pharmaceutical Dotinurad Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ziska Pharmaceutical Dotinurad Tablets Product Portfolio
6.4.5 Ziska Pharmaceutical Recent Developments/Updates
6.5 General Pharmaceuticals
6.5.1 General Pharmaceuticals Company Information
6.5.2 General Pharmaceuticals Description and Business Overview
6.5.3 General Pharmaceuticals Dotinurad Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 General Pharmaceuticals Dotinurad Tablets Product Portfolio
6.5.5 General Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dotinurad Tablets Industry Chain Analysis
7.2 Dotinurad Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dotinurad Tablets Production Mode & Process Analysis
7.4 Dotinurad Tablets Sales and Marketing
7.4.1 Dotinurad Tablets Sales Channels
7.4.2 Dotinurad Tablets Distributors
7.5 Dotinurad Tablets Customer Analysis
8 Dotinurad Tablets Market Dynamics
8.1 Dotinurad Tablets Industry Trends
8.2 Dotinurad Tablets Market Drivers
8.3 Dotinurad Tablets Market Challenges
8.4 Dotinurad Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dotinurad Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Dotinurad Tablets Market Value by Technology (US$ Million), 2025 vs 2032
 Table 3. Global Dotinurad Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Dotinurad Tablets Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Dotinurad Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 6. Global Dotinurad Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Dotinurad Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Dotinurad Tablets Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Dotinurad Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Dotinurad Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Dotinurad Tablets, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Dotinurad Tablets, Product Types and Applications
 Table 13. Global Key Manufacturers of Dotinurad Tablets, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Dotinurad Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dotinurad Tablets Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Dotinurad Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Dotinurad Tablets Sales by Region (K Units), 2021–2026
 Table 19. Global Dotinurad Tablets Sales Market Share by Region (2021–2026)
 Table 20. Global Dotinurad Tablets Sales by Region (K Units), 2027–2032
 Table 21. Global Dotinurad Tablets Sales Market Share by Region (2027–2032)
 Table 22. Global Dotinurad Tablets Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Dotinurad Tablets Revenue Market Share by Region (2021–2026)
 Table 24. Global Dotinurad Tablets Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Dotinurad Tablets Revenue Market Share by Region (2027–2032)
 Table 26. North America Dotinurad Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Dotinurad Tablets Sales by Country (K Units), 2021–2026
 Table 28. North America Dotinurad Tablets Sales by Country (K Units), 2027–2032
 Table 29. North America Dotinurad Tablets Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Dotinurad Tablets Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Dotinurad Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Dotinurad Tablets Sales by Country (K Units), 2021–2026
 Table 33. Europe Dotinurad Tablets Sales by Country (K Units), 2027–2032
 Table 34. Europe Dotinurad Tablets Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Dotinurad Tablets Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Dotinurad Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Dotinurad Tablets Sales by Region (K Units), 2021–2026
 Table 38. Asia Pacific Dotinurad Tablets Sales by Region (K Units), 2027–2032
 Table 39. Asia Pacific Dotinurad Tablets Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Dotinurad Tablets Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Dotinurad Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Dotinurad Tablets Sales by Country (K Units), 2021–2026
 Table 43. Latin America Dotinurad Tablets Sales by Country (K Units), 2027–2032
 Table 44. Latin America Dotinurad Tablets Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Dotinurad Tablets Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Dotinurad Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Dotinurad Tablets Sales by Country (K Units), 2021–2026
 Table 48. Middle East and Africa Dotinurad Tablets Sales by Country (K Units), 2027–2032
 Table 49. Middle East and Africa Dotinurad Tablets Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Dotinurad Tablets Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Dotinurad Tablets Sales (K Units) by Type (2021–2026)
 Table 52. Global Dotinurad Tablets Sales (K Units) by Type (2027–2032)
 Table 53. Global Dotinurad Tablets Sales Market Share by Type (2021–2026)
 Table 54. Global Dotinurad Tablets Sales Market Share by Type (2027–2032)
 Table 55. Global Dotinurad Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Dotinurad Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Dotinurad Tablets Revenue Market Share by Type (2021–2026)
 Table 58. Global Dotinurad Tablets Revenue Market Share by Type (2027–2032)
 Table 59. Global Dotinurad Tablets Price (US$/Unit) by Type (2021–2026)
 Table 60. Global Dotinurad Tablets Price (US$/Unit) by Type (2027–2032)
 Table 61. Global Dotinurad Tablets Sales (K Units) by Application (2021–2026)
 Table 62. Global Dotinurad Tablets Sales (K Units) by Application (2027–2032)
 Table 63. Global Dotinurad Tablets Sales Market Share by Application (2021–2026)
 Table 64. Global Dotinurad Tablets Sales Market Share by Application (2027–2032)
 Table 65. Global Dotinurad Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Dotinurad Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Dotinurad Tablets Revenue Market Share by Application (2021–2026)
 Table 68. Global Dotinurad Tablets Revenue Market Share by Application (2027–2032)
 Table 69. Global Dotinurad Tablets Price (US$/Unit) by Application (2021–2026)
 Table 70. Global Dotinurad Tablets Price (US$/Unit) by Application (2027–2032)
 Table 71. Fuji Yakuhin Company Information
 Table 72. Fuji Yakuhin Description and Business Overview
 Table 73. Fuji Yakuhin Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 74. Fuji Yakuhin Dotinurad Tablets Product
 Table 75. Fuji Yakuhin Recent Developments/Updates
 Table 76. Mochida Pharmaceutical Company Information
 Table 77. Mochida Pharmaceutical Description and Business Overview
 Table 78. Mochida Pharmaceutical Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 79. Mochida Pharmaceutical Dotinurad Tablets Product
 Table 80. Mochida Pharmaceutical Recent Developments/Updates
 Table 81. Eisai Company Information
 Table 82. Eisai Description and Business Overview
 Table 83. Eisai Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 84. Eisai Dotinurad Tablets Product
 Table 85. Eisai Recent Developments/Updates
 Table 86. Ziska Pharmaceutical Company Information
 Table 87. Ziska Pharmaceutical Description and Business Overview
 Table 88. Ziska Pharmaceutical Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 89. Ziska Pharmaceutical Dotinurad Tablets Product
 Table 90. Ziska Pharmaceutical Recent Developments/Updates
 Table 91. General Pharmaceuticals Company Information
 Table 92. General Pharmaceuticals Description and Business Overview
 Table 93. General Pharmaceuticals Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 94. General Pharmaceuticals Dotinurad Tablets Product
 Table 95. General Pharmaceuticals Recent Developments/Updates
 Table 96. Key Raw Materials Lists
 Table 97. Raw Materials Key Suppliers Lists
 Table 98. Dotinurad Tablets Distributors List
 Table 99. Dotinurad Tablets Customers List
 Table 100. Dotinurad Tablets Market Trends
 Table 101. Dotinurad Tablets Market Drivers
 Table 102. Dotinurad Tablets Market Challenges
 Table 103. Dotinurad Tablets Market Restraints
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dotinurad Tablets
 Figure 2. Global Dotinurad Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Dotinurad Tablets Market Share by Type: 2025 & 2032
 Figure 4. 0.5mg per Tablet Product Picture
 Figure 5. 1.0mg per Tablet Product Picture
 Figure 6. 2.0mg per Tablet Product Picture
 Figure 7. Global Dotinurad Tablets Market Value by Technology (US$ Million), 2021–2032
 Figure 8. Global Dotinurad Tablets Market Share by Technology: 2025 vs 2032
 Figure 9. Original Drug Product Picture
 Figure 10. Generic Drug Product Picture
 Figure 11. Global Dotinurad Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 12. Global Dotinurad Tablets Market Share by Application: 2025 & 2032
 Figure 13. Hyperuricaemia
 Figure 14. Gout
 Figure 15. Other
 Figure 16. Global Dotinurad Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Dotinurad Tablets Market Size (US$ Million), 2021–2032
 Figure 18. Global Dotinurad Tablets Sales (K Units), 2021–2032
 Figure 19. Global Dotinurad Tablets Average Price (US$/Unit), 2021–2032
 Figure 20. Dotinurad Tablets Report Years Considered
 Figure 21. Dotinurad Tablets Sales Share by Manufacturers in 2025
 Figure 22. Global Dotinurad Tablets Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Dotinurad Tablets Players: Market Share by Revenue in Dotinurad Tablets in 2025
 Figure 24. Dotinurad Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Dotinurad Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Dotinurad Tablets Sales Market Share by Country (2021–2032)
 Figure 27. North America Dotinurad Tablets Revenue Market Share by Country (2021–2032)
 Figure 28. United States Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Dotinurad Tablets Sales Market Share by Country (2021–2032)
 Figure 31. Europe Dotinurad Tablets Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Dotinurad Tablets Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Dotinurad Tablets Revenue Market Share by Region (2021–2032)
 Figure 39. China Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Southeast Asia Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Dotinurad Tablets Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Dotinurad Tablets Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Colombia Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Dotinurad Tablets Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Dotinurad Tablets Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Dotinurad Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Dotinurad Tablets by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Dotinurad Tablets by Type (2021–2032)
 Figure 59. Global Dotinurad Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Dotinurad Tablets by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Dotinurad Tablets by Application (2021–2032)
 Figure 62. Global Dotinurad Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 63. Dotinurad Tablets Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String